ARCT — ARCTURUS THERAPEUTICS HLDGS

Ownership history in Caption Management, LLC  ·  27 quarters on record

This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in ARCTURUS THERAPEUTICS HLDGS (ARCT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.04% (2025 Q3)
Avg. % of fund
0.01%
First filed
2021 Q3
Last filed
2025 Q3
Quarters held
27
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 83,500 -221,900 -72.7% 0.01% $1.5M $18.43
2025 Q3 ADDED 305,400 +246,936 +422.4% 0.04% $5.6M $18.43
2025 Q3 ADDED 58,464 +29,564 +102.3% 0.01% $1.1M $18.43
2025 Q2 REDUCED 28,900 -59,000 -67.1% 0.00% $376K $13.01
23 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ARCT price (monthly, adj. close)

Other funds also holding ARCT

As of 2025 Q4 — sorted by position size

nVerses Capital, LLC 0.31% Green Alpha Advisors, LLC 3Y 0.16% Amova Asset Management Americas, Inc. 3Y 7Y 0.14% Empire Life Investments Inc. 3Y 7Y 0.14% ARK Investment Management LLC 3Y 7Y 0.11% Atom Investors LP 3Y 7Y 0.05% Hennion & Walsh Asset Management, Inc. 3Y 0.05% AXQ CAPITAL, LP 3Y 0.04% IQ EQ FUND MANAGEMENT (IRELAND) Ltd 3Y 7Y 0.04% FEDERATED HERMES, INC. 3Y 7Y 0.03%
← Back to Caption Management, LLC Holdings